Affinivax Appoints Elizabeth Radcliffe as Chief Financial Officer
Published: May 05, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform, today announced that Elizabeth Radcliffe has joined the company as Chief Financial Officer. She is a strategic business leader with deep experience managing finance and planning across the full range of biopharmaceutical R&D, commercial and business operations, including leadership roles at Arrakis Therapeutics, Agios Pharmaceuti...